WallStreetZenWallStreetZen

NASDAQ: MIRA
Mira Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MIRA

Based on 1 analyst offering 12 month price targets for Mira Pharmaceuticals Inc

Min Forecast
$3.50+538.69%
Avg Forecast
$3.50+538.69%
Max Forecast
$3.50+538.69%

Should I buy or sell MIRA stock?

Based on 1 analyst offering ratings for Mira Pharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MIRA stock forecasts and price targets.

MIRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-17

1 of 1

Forecast return on equity

Is MIRA forecast to generate an efficient return?

Company
N/A
Industry
0.25%
Market
176.67%

Forecast return on assets

Is MIRA forecast to generate an efficient return on assets?

Company
N/A
Industry
26.84%

MIRA earnings per share forecast

What is MIRA's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.12
Avg 2 year Forecast
-$0.16
Avg 3 year Forecast
-$0.18

MIRA revenue forecast

What is MIRA's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

MIRA vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
MIRA$0.55$3.50+538.69%Strong Buy
SCLX$1.85N/AN/A
NSRX$3.07$7.00+128.01%Strong Buy
MDCX$1.88N/AN/A
AMRN$12.11$13.00+7.35%Strong Sell
View Top General Drug Manufacturer Stocks

Mira Pharmaceuticals Stock Forecast FAQ

Is Mira Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MIRA) stock is to Strong Buy MIRA stock.

Out of 1 analyst, 1 (100%) are recommending MIRA as a Strong Buy, 0 (0%) are recommending MIRA as a Buy, 0 (0%) are recommending MIRA as a Hold, 0 (0%) are recommending MIRA as a Sell, and 0 (0%) are recommending MIRA as a Strong Sell.

If you're new to stock investing, here's how to buy Mira Pharmaceuticals stock.

What is MIRA's earnings growth forecast for 2026-2028?

(NASDAQ: MIRA) Mira Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 39.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.55%.

Mira Pharmaceuticals's earnings in 2026 is -$10,741,703.On average, 3 Wall Street analysts forecast MIRA's earnings for 2026 to be -$5,143,503, with the lowest MIRA earnings forecast at -$4,941,797, and the highest MIRA earnings forecast at -$5,294,783. On average, 3 Wall Street analysts forecast MIRA's earnings for 2027 to be -$6,858,005, with the lowest MIRA earnings forecast at -$6,589,063, and the highest MIRA earnings forecast at -$7,059,711.

In 2028, MIRA is forecast to generate -$7,715,255 in earnings, with the lowest earnings forecast at -$7,412,696 and the highest earnings forecast at -$7,942,174.

What is MIRA's revenue growth forecast for 2026-2028?

(NASDAQ: MIRA) Mira Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.67%.

Mira Pharmaceuticals's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast MIRA's revenue for 2026 to be $0, with the lowest MIRA revenue forecast at $0, and the highest MIRA revenue forecast at $0. On average, 3 Wall Street analysts forecast MIRA's revenue for 2027 to be $0, with the lowest MIRA revenue forecast at $0, and the highest MIRA revenue forecast at $0.

In 2028, MIRA is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is MIRA's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MIRA) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 26.84%.

What is MIRA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MIRA price target, the average MIRA price target is $3.50, with the highest MIRA stock price forecast at $3.50 and the lowest MIRA stock price forecast at $3.50.

The Wall Street analyst predicted that Mira Pharmaceuticals's share price could reach $3.50 by Sep 17, 2027. The average Mira Pharmaceuticals stock price prediction forecasts a potential upside of 538.69% from the current MIRA share price of $0.55.

What is MIRA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MIRA) Mira Pharmaceuticals's current Earnings Per Share (EPS) is -$0.11. On average, analysts forecast that MIRA's EPS will be -$0.12 for 2026, with the lowest EPS forecast at -$0.12, and the highest EPS forecast at -$0.13. On average, analysts forecast that MIRA's EPS will be -$0.16 for 2027, with the lowest EPS forecast at -$0.16, and the highest EPS forecast at -$0.17. In 2028, MIRA's EPS is forecast to hit -$0.18 (min: -$0.18, max: -$0.19).

What is MIRA's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MIRA) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.